Soc. Generale Knock-Out VLK/ DE000SU2CK98 /
08/11/2024 10:24:47 | Chg.+0.02 | Bid20:00:02 | Ask20:00:02 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.99EUR | +0.50% | - Bid Size: - |
- Ask Size: - |
Van Lanschot Kempen ... | 21.9401 EUR | 31/12/2078 | Call |
GlobeNewswire
26/06
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire
25/06
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire
25/06
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire
04/03
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire
29/02
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire
22/12/2023
Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire
10/10/2023
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
GlobeNewswire
09/02/2021
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire
26/06/2020
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire
24/06/2020
Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire
19/06/2020
Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire
18/06/2020
Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire
17/06/2020
Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire
03/06/2020
Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire
22/01/2020
Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement